Bitcoin is set to record a gain of at least 9% this September, defying its historical trend of negative returns for the month ...

Ora Banda Mining (OBM – Research Report) received a Hold rating and a A$0.66 price target from MA Financial Group analyst Paul Hissey ...

In a report released today, James Goodman from Barclays maintained a Sell rating on Sage Group plc (SGE – Research Report). The company’s shares closed last Friday at p1,026.00. According to TipRanks, ...

Goldman Sachs analyst Tito Labarta maintained a Buy rating on Everest Group (EG – Research Report) today. The company’s shares ...

In a report released today, Georgina Fraser CFA from Goldman Sachs maintained a Buy rating on LANXESS (LNXSF – Research Report), with a ...

In a report released today, Georgina Fraser CFA from Goldman Sachs maintained a Hold rating on BASF SE (0BFA – Research Report), with a ...

RBC Capital analyst Erwan Kerouredan maintained a Sell rating on Ceres Power Holdings (CWR – Research Report) on September 27 and set a price target of p160.00. The company’s shares closed last Friday ...

MannKind (MNKD) reported top-level 30-week results from Phase 4 INHALE-3 study, in which additional patients living with type 1 ...

At the 2024 FORTUNE Global 500 Summit in Guangzhou on September 26th, Dr. Shen Jianguang, Chief Economist of JD.com, ...

KeyBanc analyst Scott Schoenhaus maintained a Hold rating on Progyny (PGNY – Research Report) today. The company’s shares closed last Friday at $16.80. Schoenhaus covers the Healthcare sector, ...

Ohtuvayre (ensifentrine) is a first-in-class selective dual inhibitor of the enzymes phosphodiesterase three and phosphodiesterase 4 (“PDE3 and PDE4”) that combines bronchodilator and non-steroidal ...

Expansion and innovation continue to drive growth as HLRBO strengthens its platform with increased funding and strategic ...